Just over a week later, the Washington Post reported again that while there was no vaccine yet for COVID-19, "We do have one potentially promising treatment to help people infected with the coronavirus: infusions of antibody-rich plasma from other patients who have had the disease and recovered."
A couple months later, the Washington Post again touted the potential of blood plasma, also called convalescent plasma, in treating the virus.
"A large study of 20,000 hospitalized covid-19 patients who received transfusions of blood plasma from people who recovered found the treatment was safe and suggests giving it to people early in the disease may be beneficial," they reported June 18, 2020, in an article headlined, "Blood plasma from people who recovered is a safe covid-19 treatment, study says."
Earlier this month, four former FDA commissioners wrote an op-ed in the Washington Post arguing that "Blood plasma might be the COVID-19 treatment we need."
According to FDA Commissioner Stephen Hahn, plasma treatments reduce mortality of COVID-19 by 35 percent suddenly, the Washington Post isn't very impressed by blood plasma as a COVID-19 treatment anymore.
The Food and Drug Administration's decision to give emergency authorization for convalescent plasma as a treatment for novel coronavirus patients - touted as a historic breakthrough by President Trump on Sunday - is raising doubts among some experts who say the therapy hasn't been adequately tested.
Will convalescent plasma meet the same fate as hydroxychloroquine? Is the media that desperate to get rid of Trump they'll scare the public away from treatments that could save their lives?
Tuesday, August 25, 2020
After Hyping Blood Plasma for Months, WaPo Changes Tune
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment